- Home
- Publications
- Publication Search
- Publication Details
Title
Trial Watch—Oncolytic viruses and cancer therapy
Authors
Keywords
-
Journal
OncoImmunology
Volume 5, Issue 2, Pages e1117740
Publisher
Informa UK Limited
Online
2015-12-09
DOI
10.1080/2162402x.2015.1117740
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus
- (2016) Kristian Taipale et al. MOLECULAR THERAPY
- VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection
- (2015) Rozanne Arulanandam et al. CANCER CELL
- Abstract CT123: Phase I/II trial of endoscopic intratumoral administration of OBP-301, a novel telomerase-specific oncolytic virus, with radiation in elderly esophageal cancer patients
- (2015) Shunsuke Tanabe et al. CANCER RESEARCH
- Abstract CT205: Intravenous delivery of a novel oncolytic immunotherapy agent, CAVATAK, in advanced cancer patients
- (2015) Hardev Pandha et al. CANCER RESEARCH
- Oncolytic Virus Immunotherapy for Melanoma
- (2015) Neal Dharmadhikari et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Targeted Oncolytic Herpes Simplex Virus Type 1 Eradicates Experimental Pancreatic Tumors
- (2015) Marion Gayral et al. HUMAN GENE THERAPY
- Talimogene laherparepvec (T-VEC) for the treatment of advanced melanoma
- (2015) Douglas B Johnson et al. Immunotherapy
- Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Resultsin vitro, in rodents and in humans
- (2015) Simona Bramante et al. INTERNATIONAL JOURNAL OF CANCER
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Newly Recruited CD11b+, GR-1+, Ly6ChighMyeloid Cells Augment Tumor-Associated Immunosuppression Immediately following the Therapeutic Administration of Oncolytic Reovirus
- (2015) Derek R. Clements et al. JOURNAL OF IMMUNOLOGY
- Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia
- (2015) C Parrish et al. LEUKEMIA
- Case–Control Estimation of the Impact of Oncolytic Adenovirus on the Survival of Patients With Refractory Solid Tumors
- (2015) Anna Kanerva et al. MOLECULAR THERAPY
- Phase 1b Trial of Biweekly Intravenous Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus in Colorectal Cancer
- (2015) Se Hoon Park et al. MOLECULAR THERAPY
- Phase 1 Study of Intratumoral Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus, in Pediatric Cancer Patients
- (2015) Timothy P Cripe et al. MOLECULAR THERAPY
- First-in-man Study of Western Reserve Strain Oncolytic Vaccinia Virus: Safety, Systemic Spread, and Antitumor Activity
- (2015) Herbert J Zeh et al. MOLECULAR THERAPY
- Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity
- (2015) Carolina S Ilkow et al. NATURE MEDICINE
- T-VEC oncolytic viral therapy shows promise in melanoma
- (2015) David Killock Nature Reviews Clinical Oncology
- Oncolytic viruses get a boost with first FDA-approval recommendation
- (2015) Elie Dolgin NATURE REVIEWS DRUG DISCOVERY
- A phase I trial and viral clearance study of reovirus (Reolysin) in children with relapsed or refractory extra-cranial solid tumors: A Children's Oncology Group Phase I Consortium report
- (2015) E . Anders Kolb et al. PEDIATRIC BLOOD & CANCER
- Microtubule disruption synergizes with oncolytic virotherapy by inhibiting interferon translation and potentiating bystander killing
- (2015) Rozanne Arulanandam et al. Nature Communications
- Immunological data from cancer patients treated with Ad5/3 E2F Δ24 GMCSF suggests utility for tumor immunotherapy
- (2015) Otto Hemminki et al. Oncotarget
- Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications
- (2015) Aitziber Buqué et al. OncoImmunology
- Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy
- (2015) Ilkka Liikanen et al. OncoImmunology
- Survivin promoter-regulated oncolytic adenovirus with Hsp70 gene exerts effective antitumor efficacy in gastric cancer immunotherapy
- (2015) Weiguo Wang et al. Oncotarget
- Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemia
- (2015) Yin Tong et al. Oncotarget
- Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-κB regulated gene products in multiple myeloma xenograft mouse model
- (2015) Kodappully Sivaraman Siveen et al. Oncotarget
- LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer
- (2015) Francesca Lovat et al. Oncotarget
- The small heat shock protein B8 (HSPB8) confers resistance to bortezomib by promoting autophagic removal of misfolded proteins in multiple myeloma cells
- (2015) Mohamed-Amine Hamouda et al. Oncotarget
- Development of replication-competent adenovirus for bladder cancer by controlling adenovirus E1a and E4 gene expression with the survivin promoter
- (2015) Ho Kyung Seo et al. Oncotarget
- The anti-tumor activator sMEK1 and paclitaxel additively decrease expression of HIF-1α and VEGF via mTORC1-S6K/4E-BP-dependent signaling pathways
- (2015) Boh-Ram Kim et al. Oncotarget
- Eradication of metastatic melanoma through cooperative expression of RNA-based HDAC1 inhibitor and p73 by oncolytic adenovirus
- (2015) Holger Schipper et al. Oncotarget
- Intrinsic bevacizumab resistance is associated with prolonged activation of autocrine VEGF signaling and hypoxia tolerance in colorectal cancer cells and can be overcome by nintedanib, a small molecule angiokinase inhibitor.
- (2015) Paul Mésange et al. Oncotarget
- Apoptin enhances the oncolytic properties of vaccinia virus and modifies mechanisms of tumor regression
- (2015) Galina Kochneva et al. Oncotarget
- Oncolytic reovirus preferentially induces apoptosis in KRAS mutant colorectal cancer cells, and synergizes with irinotecan
- (2015) Radhashree Maitra et al. Oncotarget
- Classification of current anticancer immunotherapies
- (2015) Lorenzo Galluzzi et al. Oncotarget
- Expression of CCL19 from Oncolytic Vaccinia Enhances Immunotherapeutic Potential while Maintaining Oncolytic Activity
- (2015) Jun Li et al. NEOPLASIA
- Combination of Oncolytic Herpes Simplex Viruses Armed with Angiostatin and IL-12 Enhances Antitumor Efficacy in Human Glioblastoma Models
- (2015) Wei Zhang et al. NEOPLASIA
- Molecular Imaging with Bioluminescence and PET Reveals Viral Oncolysis Kinetics and Tumor Viability
- (2014) D. Kuruppu et al. CANCER RESEARCH
- Armed Oncolytic Virus Enhances Immune Functions of Chimeric Antigen Receptor-Modified T Cells in Solid Tumors
- (2014) N. Nishio et al. CANCER RESEARCH
- Viruses for Tumor Therapy
- (2014) John Bell et al. Cell Host & Microbe
- A Phase I Trial of Single-Agent Reolysin in Patients with Relapsed Multiple Myeloma
- (2014) D. W. Sborov et al. CLINICAL CANCER RESEARCH
- Phase I Trial of Cyclophosphamide as an Immune Modulator for Optimizing Oncolytic Reovirus Delivery to Solid Tumors
- (2014) V. Roulstone et al. CLINICAL CANCER RESEARCH
- Bortezomib-Induced Unfolded Protein Response Increases Oncolytic HSV-1 Replication Resulting in Synergistic Antitumor Effects
- (2014) J. Y. Yoo et al. CLINICAL CANCER RESEARCH
- Genetic delivery of an immunoRNase by an oncolytic adenovirus enhances anticancer activity
- (2014) Inés Fernández-Ulibarri et al. INTERNATIONAL JOURNAL OF CANCER
- Prospective Randomized Phase 2 Trial of Intensity Modulated Radiation Therapy With or Without Oncolytic Adenovirus-Mediated Cytotoxic Gene Therapy in Intermediate-Risk Prostate Cancer
- (2014) Svend O. Freytag et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- CXCL12/CXCR4 Blockade by Oncolytic Virotherapy Inhibits Ovarian Cancer Growth by Decreasing Immunosuppression and Targeting Cancer-Initiating Cells
- (2014) Margaret Gil et al. JOURNAL OF IMMUNOLOGY
- Autonomous Parvoviruses neither Stimulate nor Are Inhibited by the Type I Interferon Response in Human Normal or Cancer Cells
- (2014) J. C. Paglino et al. JOURNAL OF VIROLOGY
- Remission of Disseminated Cancer After Systemic Oncolytic Virotherapy
- (2014) Stephen J. Russell et al. MAYO CLINIC PROCEEDINGS
- CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy
- (2014) Christine E Engeland et al. MOLECULAR THERAPY
- Phase 1 Clinical Trial of Intratumoral Reovirus Infusion for the Treatment of Recurrent Malignant Gliomas in Adults
- (2014) Kimberly P Kicielinski et al. MOLECULAR THERAPY
- A Phase 1 Trial of Oncolytic HSV-1, G207, Given in Combination With Radiation for Recurrent GBM Demonstrates Safety and Radiographic Responses
- (2014) James M Markert et al. MOLECULAR THERAPY
- Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
- (2014) Antonella Sistigu et al. NATURE MEDICINE
- Oncogenic Ras inhibits IRF1 to promote viral oncolysis
- (2014) Y Komatsu et al. ONCOGENE
- Phase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: A report of the Children's Oncology Group
- (2014) Michael J. Burke et al. PEDIATRIC BLOOD & CANCER
- The In Vivo Therapeutic Efficacy of the Oncolytic Adenovirus Delta24-RGD Is Mediated by Tumor-Specific Immunity
- (2014) Anne Kleijn et al. PLoS One
- Combining low-dose or metronomic chemotherapy with anticancer vaccines
- (2014) Heng Sheng Sow et al. OncoImmunology
- Novel immune checkpoint blocker approved for the treatment of advanced melanoma
- (2014) Lorenzo Galluzzi et al. OncoImmunology
- The therapeutic efficacy of the oncolytic virus Delta24-RGD in a murine glioma model depends primarily on antitumor immunity
- (2014) Anne Kleijn et al. OncoImmunology
- Monocytic myeloid-derived suppressor cells in advanced melanoma patients
- (2014) Alexander Martens et al. OncoImmunology
- Trial Watch
- (2014) Fernando Aranda et al. OncoImmunology
- Healing after death: antitumor immunity induced by oncolytic adenoviral therapy
- (2014) Hong Jiang et al. OncoImmunology
- Tumor-associated antigen specific CD8+T cells in hepatocellular carcinoma – a promising target for immunotherapy
- (2014) Nathalie Schmidt et al. OncoImmunology
- Trial Watch: Radioimmunotherapy for oncological indications
- (2014) Norma Bloy et al. OncoImmunology
- Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy
- (2014) Irena Adkins et al. OncoImmunology
- AMD3100 protects from UV-induced skin cancer
- (2014) Scott N Byrne et al. OncoImmunology
- Immunovirotherapy for the treatment of glioblastoma
- (2014) Tooba A Cheema et al. OncoImmunology
- Trial Watch
- (2014) Fernando Aranda et al. OncoImmunology
- Local treatment of a pleural mesothelioma tumor with ONCOS-102 induces a systemic antitumor CD8+T-cell response, prominent infiltration of CD8+lymphocytes and Th1 type polarization
- (2014) Tuuli Ranki et al. OncoImmunology
- Dual targeting of CD137 co-stimulatory and PD-1 co-inhibitory molecules for ovarian cancer immunotherapy
- (2014) Huafeng Wei et al. OncoImmunology
- Trial watch
- (2014) Erika Vacchelli et al. OncoImmunology
- Targeting human CD27 with an agonist antibody stimulates T-cell activation and antitumor immunity
- (2014) Lawrence J Thomas et al. OncoImmunology
- Two is better than one: Complementing oncolytic virotherapy with gemcitabine to potentiate antitumor immune responses
- (2014) Shashi Gujar et al. OncoImmunology
- Metronomic cyclophosphamide enhances HPV16E7 peptide vaccine induced antigen-specific and cytotoxic T-cell mediated antitumor immune response
- (2014) Genevieve M Weir et al. OncoImmunology
- Tumor stroma-derived factors skew monocyte to dendritic cell differentiation toward a suppressive CD14+PD-L1+phenotype in prostate cancer
- (2014) Lisa K Spary et al. OncoImmunology
- Trial Watch
- (2014) Fernando Aranda et al. OncoImmunology
- Unleashing the immune system: PD-1 and PD-Ls in the pre-treatment tumor microenvironment and correlation with response to PD-1/PD-L1 blockade
- (2014) Janis M Taube OncoImmunology
- Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death
- (2014) Encouse B Golden et al. OncoImmunology
- Trial Watch:
- (2014) Jonathan Pol et al. OncoImmunology
- Consensus guidelines for the detection of immunogenic cell death
- (2014) Oliver Kepp et al. OncoImmunology
- Trial Watch
- (2014) Erika Vacchelli et al. OncoImmunology
- Trial Watch
- (2014) Erika Vacchelli et al. OncoImmunology
- Immunoglobulin-like transcript 2 (ILT2) is a biomarker of therapeutic response to oncolytic immunotherapy with vaccinia viruses
- (2014) Andrew Zloza et al. Journal for ImmunoTherapy of Cancer
- Oncolytic Viruses as Anticancer Vaccines
- (2014) Norman Woller et al. Frontiers in Oncology
- Immunotherapeutic Potential of Oncolytic Vaccinia Virus
- (2014) Steve H. Thorne Frontiers in Oncology
- Human mesenchymal stromal cells deliver systemic oncolytic measles virus to treat acute lymphoblastic leukemia in the presence of humoral immunity
- (2013) A. Castleton et al. BLOOD
- Oncolytic adenovirus encoding tumor necrosis factor-related apoptosis inducing ligand (TRAIL) inhibits the growth and metastasis of triple-negative breast cancer
- (2013) Wei Zhu et al. CANCER BIOLOGY & THERAPY
- Toca 511 gene transfer and 5-fluorocytosine in combination with temozolomide demonstrates synergistic therapeutic efficacy in a temozolomide-sensitive glioblastoma model
- (2013) T T Huang et al. CANCER GENE THERAPY
- Myeloid-Derived Suppressor Cells as a Vehicle for Tumor-Specific Oncolytic Viral Therapy
- (2013) S. Eisenstein et al. CANCER RESEARCH
- Specific Elimination of CD133+ Tumor Cells with Targeted Oncolytic Measles Virus
- (2013) P. Bach et al. CANCER RESEARCH
- Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF-Coding Oncolytic Adenovirus
- (2013) A. Kanerva et al. CLINICAL CANCER RESEARCH
- Anti-tumor effects of inactivated Sendai virus particles with an IL-2 gene on angiosarcoma
- (2013) Yuki Takehara et al. CLINICAL IMMUNOLOGY
- Current status of gene therapy for cancer
- (2013) Wolfgang Walther et al. CURRENT OPINION IN ONCOLOGY
- Efficacy of oncolytic adenovirus expressing suicide genes and interleukin-12 in preclinical model of prostate cancer
- (2013) S O Freytag et al. GENE THERAPY
- An armed oncolytic measles vaccine virus eliminates human hepatoma cells independently of apoptosis
- (2013) J Lampe et al. GENE THERAPY
- CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging
- (2013) S Parviainen et al. GENE THERAPY
- Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytosine deaminase and uracil phosphoribosyltransferase
- (2013) A.D. Hartkopf et al. GYNECOLOGIC ONCOLOGY
- Telomerase-specific oncolytic adenovirus: Antitumor effects on radiation-resistant head and neck squamous cell carcinoma cells
- (2013) Hideaki Takahashi et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Granulocyte-Macrophage Colony-Stimulating Factor-Armed Oncolytic Measles Virus Is an Effective Therapeutic Cancer Vaccine
- (2013) Christian Grossardt et al. HUMAN GENE THERAPY
- Tat-PTD-Modified Oncolytic Adenovirus Driven by the SCG3 Promoter and ASH1 Enhancer for Neuroblastoma Therapy
- (2013) Chuan Jin et al. HUMAN GENE THERAPY
- Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
- (2013) Laurence Zitvogel et al. IMMUNITY
- The role of GM-CSF in enhancing immunotherapy of cancer
- (2013) Steve H Thorne Immunotherapy
- Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans
- (2013) Simona Bramante et al. INTERNATIONAL JOURNAL OF CANCER
- Therapeutic targeting of chitosan–PEG–folate-complexed oncolytic adenovirus for active and systemic cancer gene therapy
- (2013) Oh-Joon Kwon et al. JOURNAL OF CONTROLLED RELEASE
- Decoding cell death signals in liver inflammation
- (2013) Catherine Brenner et al. JOURNAL OF HEPATOLOGY
- Systemically delivered measles virus-infected mesenchymal stem cells can evade host immunity to inhibit liver cancer growth
- (2013) Hooi-Tin Ong et al. JOURNAL OF HEPATOLOGY
- Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model
- (2013) Wenjia Lou et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Live viruses to treat cancer
- (2013) Oliver Donnelly et al. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE
- Optimizing patient derived mesenchymal stem cells as virus carriers for a Phase I clinical trial in ovarian cancer
- (2013) Emily K Mader et al. Journal of Translational Medicine
- Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry
- (2013) Bo Kim et al. Journal of Translational Medicine
- Prostate-Specific Antigen-Retargeted Recombinant Newcastle Disease Virus for Prostate Cancer Virotherapy
- (2013) R. Shobana et al. JOURNAL OF VIROLOGY
- Neuroattenuation of Vesicular Stomatitis Virus through Picornaviral Internal Ribosome Entry Sites
- (2013) A. Ammayappan et al. JOURNAL OF VIROLOGY
- Cancer targeting gene-viro-therapy for pancreatic cancer using oncolytic adenovirus ZD55-IL-24 in immune-competent mice
- (2013) Bin He et al. MOLECULAR BIOLOGY REPORTS
- An oncolytic adenovirus expressing interleukin-24 enhances antitumor activities in combination with paclitaxel in breast cancer cells
- (2013) LIN FANG et al. Molecular Medicine Reports
- HDAC Inhibition Suppresses Primary Immune Responses, Enhances Secondary Immune Responses, and Abrogates Autoimmunity During Tumor Immunotherapy
- (2013) Byram W Bridle et al. MOLECULAR THERAPY
- Oncolytic Adenovirus With Temozolomide Induces Autophagy and Antitumor Immune Responses in Cancer Patients
- (2013) Ilkka Liikanen et al. MOLECULAR THERAPY
- Maraba Virus as a Potent Oncolytic Vaccine Vector
- (2013) Jonathan G Pol et al. MOLECULAR THERAPY
- Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
- (2013) Jeong Heo et al. NATURE MEDICINE
- MicroRNA-Mediated Suppression of Oncolytic Adenovirus Replication in Human Liver
- (2013) Erkko Ylösmäki et al. PLoS One
- Molecular Basis for Viral Selective Replication in Cancer Cells: Activation of CDK2 by Adenovirus-Induced Cyclin E
- (2013) Pei-Hsin Cheng et al. PLoS One
- Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus
- (2013) Elisa Callegari et al. PLoS One
- Oncolytic Adenovirus Expressing IL-23 and p35 Elicits IFN-γ- and TNF-α-Co-Producing T Cell-Mediated Antitumor Immunity
- (2013) Il-Kyu Choi et al. PLoS One
- STAT3 Activation Promotes Oncolytic HSV1 Replication in Glioma Cells
- (2013) Kazuo Okemoto et al. PLoS One
- Production of Bioactive Soluble Interleukin-15 in Complex with Interleukin-15 Receptor Alpha from a Conditionally-Replicating Oncolytic HSV-1
- (2013) David C. Gaston et al. PLoS One
- A dual-regulated oncolytic adenovirus expressing interleukin-24 sensitizes melanoma cells to temozolomide via the induction of apoptosis
- (2013) Guan Jiang et al. TUMOR BIOLOGY
- MicroRNA-145 regulates oncolytic herpes simplex virus-1 for selective killing of human non-small cell lung cancer cells
- (2013) Jhy-Ming Li et al. Virology Journal
- Preclinical evaluation of herpes simplex virus armed with granulocyte-macrophage colony-stimulating factor in pancreatic carcinoma
- (2013) Hao Liu WORLD JOURNAL OF GASTROENTEROLOGY
- Non-replicating rhabdovirus-derived particles (NRRPs) eradicate acute leukemia by direct cytolysis and induction of antitumor immunity
- (2013) C Batenchuk et al. Blood Cancer Journal
- Preclinical Therapy of Disseminated HER-2+ Ovarian and Breast Carcinomas with a HER-2-Retargeted Oncolytic Herpesvirus
- (2013) Patrizia Nanni et al. PLoS Pathogens
- Natural Oncolytic Activity of Live-Attenuated Measles Virus against Human Lung and Colorectal Adenocarcinomas
- (2013) Nicolas Boisgerault et al. Biomed Research International
- The IL-15-based superagonist ALT-803 promotes the antigen-independent conversion of memory CD8+T cells into innate-like effector cells with antitumor activity
- (2013) Hing C Wong et al. OncoImmunology
- MAGE-A3-specific anticancer immunotherapy in the clinical practice
- (2013) Vincent G. Brichard et al. OncoImmunology
- Myeloid-derived suppressor cells as a Trojan horse
- (2013) Ping-Ying Pan et al. OncoImmunology
- Myeloid derived suppressor cells
- (2013) Todd J. Waldron et al. OncoImmunology
- Uncovering a novel mechanism whereby NK cells interfere with glioblastoma virotherapy
- (2013) Christopher A. Alvarez-Breckenridge et al. OncoImmunology
- Attenuated measles virus used as an oncolytic virus activates myeloid and plasmacytoid dendritic cells
- (2013) Jean-François Fonteneau et al. OncoImmunology
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Antitumor activity of an immunocytokine composed of an anti-GD2 antibody and the IL-15 superagonist RLI
- (2013) Marie Vincent et al. OncoImmunology
- Phase I study of the CD40 agonist antibody CP-870,893 combined with carboplatin and paclitaxel in patients with advanced solid tumors
- (2013) Robert H. Vonderheide et al. OncoImmunology
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Immune effects of 5-fluorouracil
- (2013) François Ghiringhelli et al. OncoImmunology
- Trial watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8+T-cell responses to anticancer vaccines
- (2013) Byram W Bridle et al. OncoImmunology
- The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4+T cells
- (2013) Shamaila Munir et al. OncoImmunology
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer models
- (2012) B J Passer et al. CANCER GENE THERAPY
- Antitumoral activity of parvovirus-mediated IL-2 and MCP-3/CCL7 delivery into human pancreatic cancer: implication of leucocyte recruitment
- (2012) Sebastian Dempe et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Potent antitumoral effects of targeted promoter-driven oncolytic adenovirus armed with Dm-dNK for breast cancer in vitro and in vivo
- (2012) Xiaoshen Dong et al. CANCER LETTERS
- Macrophage Delivery of an Oncolytic Virus Abolishes Tumor Regrowth and Metastasis after Chemotherapy or Irradiation
- (2012) M. Muthana et al. CANCER RESEARCH
- Sorafenib Has Potent Antitumor Activity against Multiple Myeloma In Vitro, Ex Vivo, and In Vivo in the 5T33MM Mouse Model
- (2012) P. Kharaziha et al. CANCER RESEARCH
- Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus
- (2012) I. Diaconu et al. CANCER RESEARCH
- Oncolytic Immunotherapy of Advanced Solid Tumors with a CD40L-Expressing Replicating Adenovirus: Assessment of Safety and Immunologic Responses in Patients
- (2012) S. Pesonen et al. CANCER RESEARCH
- Clinical Development of Oncolytic Viruses in China
- (2012) Min Liang CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Cytotoxic and immune-mediated killing of human colorectal cancer by reovirus-loaded blood and liver mononuclear cells
- (2012) Robert A. Adair et al. INTERNATIONAL JOURNAL OF CANCER
- Telomerase-specific oncolytic adenoviral therapy for orthotopic hepatocellular carcinoma in HBx transgenic mice
- (2012) Wei-Hsiang Lin et al. INTERNATIONAL JOURNAL OF CANCER
- Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cells
- (2012) Huiqiang Wang et al. Journal of Translational Medicine
- A First in Human Phase 1 Study of CG0070, a GM-CSF Expressing Oncolytic Adenovirus, for the Treatment of Nonmuscle Invasive Bladder Cancer
- (2012) James M. Burke et al. JOURNAL OF UROLOGY
- Design and Selection of Toca 511 for Clinical Use: Modified Retroviral Replicating Vector With Improved Stability and Gene Expression
- (2012) Omar D Perez et al. MOLECULAR THERAPY
- Effective Treatment of an Orthotopic Xenograft Model of Human Glioblastoma Using an EGFR-retargeted Oncolytic Herpes Simplex Virus
- (2012) Hiroaki Uchida et al. MOLECULAR THERAPY
- Tropism ablation and stealthing of oncolytic adenovirus enhances systemic delivery to tumors and improves virotherapy of cancer
- (2012) Nicola K Green et al. Nanomedicine
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- The secret ally: immunostimulation by anticancer drugs
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- The combination of an oxygen-dependent degradation domain-regulated adenovirus expressing the chemokine RANTES/CCL5 and NK-92 cells exerts enhanced antitumor activity in hepatocellular carcinoma
- (2012) JIANG LI et al. ONCOLOGY REPORTS
- Oncolytic Effects of a Novel Influenza A Virus Expressing Interleukin-15 from the NS Reading Frame
- (2012) Marijke van Rikxoort et al. PLoS One
- Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells
- (2012) P Kharaziha et al. Cell Death & Disease
- Interleukin-2 treatment of tumor patients can expand regulatory T cells
- (2012) Marc Beyer OncoImmunology
- Single low-dose cyclophosphamide combined with interleukin-12 gene therapy is superior to a metronomic schedule in inducing immunity against colorectal carcinoma in mice
- (2012) Mariana Malvicini et al. OncoImmunology
- Chemoimmunotherapy as long-term maintenance therapy for cancer
- (2012) Nejat K. Egilmez et al. OncoImmunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- NKG2D ligands link oncogenic RAS to innate immunity
- (2012) Samantha S.W. Ho et al. OncoImmunology
- Immunogenic tumor cell death induced by chemoradiotherapy in a clinical setting
- (2012) Koji Kono et al. OncoImmunology
- Enhancing VSV oncolytic activity with an improved cytosine deaminase suicide gene strategy
- (2011) S Leveille et al. CANCER GENE THERAPY
- Expressing human interleukin-15 from oncolytic vesicular stomatitis virus improves survival in a murine metastatic colon adenocarcinoma model through the enhancement of anti-tumor immunity
- (2011) K B Stephenson et al. CANCER GENE THERAPY
- Enhanced Safety Profiles of the Telomerase-Specific Replication-Competent Adenovirus by Incorporation of Normal Cell-Specific microRNA-Targeted Sequences
- (2011) K. Sugio et al. CLINICAL CANCER RESEARCH
- Retargeting Vesicular Stomatitis Virus Using Measles Virus Envelope Glycoproteins
- (2011) Camilo Ayala-Breton et al. HUMAN GENE THERAPY
- Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors
- (2011) Sari Pesonen et al. INTERNATIONAL JOURNAL OF CANCER
- Pseudotyping Vesicular Stomatitis Virus with Lymphocytic Choriomeningitis Virus Glycoproteins Enhances Infectivity for Glioma Cells and Minimizes Neurotropism
- (2011) A. Muik et al. JOURNAL OF VIROLOGY
- Optimizing DC Vaccination by Combination With Oncolytic Adenovirus Coexpressing IL-12 and GM-CSF
- (2011) Song-Nan Zhang et al. MOLECULAR THERAPY
- Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector
- (2011) D. Ostertag et al. NEURO-ONCOLOGY
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Identification of the ENT1 Antagonists Dipyridamole and Dilazep as Amplifiers of Oncolytic Herpes Simplex Virus-1 Replication
- (2010) B. J. Passer et al. CANCER RESEARCH
- High Therapeutic Potential for Systemic Delivery of a Liposomeconjugated Herpes Simplex Virus
- (2010) T. Shikano et al. CURRENT CANCER DRUG TARGETS
- Preparing an oncolytic poliovirus recombinant for clinical application against glioblastoma multiforme
- (2010) Christian Goetz et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Phase I/II Study of Oncolytic Herpes Simplex Virus NV1020 in Patients with Extensively Pretreated Refractory Colorectal Cancer Metastatic to the Liver
- (2010) Sunil K. Geevarghese et al. HUMAN GENE THERAPY
- Transcriptional and Translational Dual-regulated Oncolytic Herpes Simplex Virus Type 1 for Targeting Prostate Tumors
- (2010) Cleo YF Lee et al. MOLECULAR THERAPY
- Potentiating Cancer Immunotherapy Using an Oncolytic Virus
- (2010) Byram W Bridle et al. MOLECULAR THERAPY
- Arsenic trioxide inhibits DNA methyltransferase and restores expression of methylation-silenced CDKN2B/CDKN2A genes in human hematologic malignant cells
- (2010) Shen ONCOLOGY REPORTS
- Initial testing of the replication competent Seneca Valley virus (NTX-010) by the pediatric preclinical testing program
- (2010) Christopher L. Morton et al. PEDIATRIC BLOOD & CANCER
- Gene Therapy: The First Approved Gene-Based Medicines, Molecular Mechanisms and Clinical Indications
- (2010) J. Raty et al. Current Molecular Pharmacology
- Antitumor Activity of an Oncolytic Adenoviral-CD40 Ligand (CD154) Transgene Construct in Human Breast Cancer Cells
- (2009) E. M. Gomes et al. CLINICAL CANCER RESEARCH
- Genetically engineered Newcastle disease virus for malignant melanoma therapy
- (2009) D Zamarin et al. GENE THERAPY
- Oncolytic adenovirus mediated Survivin knockdown by RNA interference suppresses human colorectal carcinoma growth in vitro and in vivo
- (2009) Wei Shen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Myxoma Virus Expressing Interleukin-15 Fails To Cause Lethal Myxomatosis in European Rabbits
- (2009) J. Liu et al. JOURNAL OF VIROLOGY
- Attenuation of Vesicular Stomatitis Virus Encephalitis through MicroRNA Targeting
- (2009) E. J. Kelly et al. JOURNAL OF VIROLOGY
- Vesicular Stomatitis Virus as a Novel Cancer Vaccine Vector to Prime Antitumor Immunity Amenable to Rapid Boosting With Adenovirus
- (2009) Byram W Bridle et al. MOLECULAR THERAPY
- Conditional and reversible disruption of essential herpesvirus proteins
- (2009) Mandy Glaß et al. NATURE METHODS
- A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer
- (2008) L. Vidal et al. CLINICAL CANCER RESEARCH
- Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus
- (2008) J Foloppe et al. GENE THERAPY
- Evaluation of IRES-mediated, cell-type-specific cytotoxicity of poliovirus using a colorimetric cell proliferation assay
- (2008) Xiaoyi Yang et al. JOURNAL OF VIROLOGICAL METHODS
- Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
- (2008) Byeong-Ho Park et al. LANCET ONCOLOGY
- Delta-24-RGD in Combination With RAD001 Induces Enhanced Anti-glioma Effect via Autophagic Cell Death
- (2008) Marta M Alonso et al. MOLECULAR THERAPY
- A let-7 MicroRNA-sensitive Vesicular Stomatitis Virus Demonstrates Tumor-specific Replication
- (2008) Robert E Edge et al. MOLECULAR THERAPY
- Chemical control of protein stability and function in living mice
- (2008) Laura A Banaszynski et al. NATURE MEDICINE
- Engineering microRNA responsiveness to decrease virus pathogenicity
- (2008) Elizabeth J Kelly et al. NATURE MEDICINE
- Viral Control of Mitochondrial Apoptosis
- (2008) Lorenzo Galluzzi et al. PLoS Pathogens
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation